You are here

Category
Technology Name
Briefcase
Scientist
1601
A potent combination therapy against non-invasive breast cancer Breast cancer is the most common cancer in females. Among the different subtypes of breast cancer, ductal carcinoma in situ (DCIS) represents an intermediate step between normal breast tissue and invasive breast cancer. Currently, about 25...

A potent combination therapy against non-invasive breast cancer

Breast cancer is the most common cancer in females. Among the different subtypes of breast cancer, ductal carcinoma in situ (DCIS) represents an intermediate step between normal breast tissue and invasive breast cancer. Currently, about 25% of breast cancers that are diagnosed in the US are DCIS. DCIS is commonly treated by surgical intervention followed by adjuvant radiation therapy. However, a significant fraction of the DCIS lesions, which display HER2 gene amplification, are associated with increased relapse rate following surgery. Therefore, in cases of HER2-overexpressing DCIS a molecularly targeted therapy might be necessary for complete eradication of microscopic remnants following surgical tumor removal. The current technology presents an potential DCIS therapeutic strategy that collectively targets the functionally linked HER2 and Notch pathways.

 

Applications


  • Combination therapy for DCIS patients following surgical tumor removal.
  • Classification of DCIS patients according to HER2 Notch activation patterns to identify patients with increased risk of relapse after surgery.
  • Diagnostic antibodies to NRG4 to screen for cancer cell subtypes that express/over-express NRG4.
  • NRG4 fusion conjugates, where NRG4 acts as a vehicle to direct the conjugate to cells specifically expressing the receptor ErbB4.

 


Advantages


  • Targeted cancer therapies will give doctors a better way to tailor cancer treatment.
  • Targeted cancer therapies hold the promise of being more selective, thus harming fewer normal cells, reducing side effects, and improving the quality of life.
  • The proposed treatment strategy may prove beneficial in DCIS patients with poor prognosis.

 


Technology's Essence


The HER2/Neu oncogene, a member of the HER/ErbB signaling network, encodes a receptor-like tyrosine kinase, whose overexpression in breast cancer predicts poor prognosis and resistance to conventional therapies. Pre-invasive lesions, such as DCIS, overexpress HER2 at higher frequency than invasive ones. Another signal transduction pathway critical for breast cancer progression comprises Notch family receptors and their membrane-bound ligands. In the current technology, a team of researchers from the Weizmann Institute of Science uncovered that overexpression of HER2 in a novel experimental model of DCIS leads to transcriptional upregulation of Notch pathway components, resulting in enhanced tumor cell survival and proliferation. Combined treatment with HER2 and Notch pathway inhibitors resulted in decreased proliferative and tumorigenic potential. The current technology offers specific and combined targeting of HER2 and Notch pathways for DCIS treatment. This approach may also be tailored for DCIS patients with enhanced co-expression of HER2 and Notch.

+
  • Prof. Yosef Yarden
1657
Bioengineered formatotrophic E.Coli can be utilized to efficiently generate biomass from electricity. A popular direction for cleantech in recent years is that of biorefineries, that use living organisms to supply the human demand for chemical commodities. Electricity is considered to be a potential...

Bioengineered formatotrophic E.Coli can be utilized to efficiently generate biomass from electricity. A popular direction for cleantech in recent years is that of biorefineries, that use living organisms to supply the human demand for chemical commodities. Electricity is considered to be a potential feedstock for biorefineries, with the end products serving as solid or liquid storage of energy.  Such microbial electrosynthesis is highly dependent on mediators to enable electron transfer from an electrode to a living cell. 
Formic acid (formate) is an electron mediator with a number of desired features for microbial electrosynthesis. However, wild-type organisms that can grow on formate are not suitable for industrial use due to slow growth rates and metabolism. 
Researchers at the Weizmann Institute have successfully engineered a formatotrophic E.coli. By combining systematical analysis with computational tools they screened numerous metabolic pathways and identified the optimized metabolic pathway that supports efficient formate-based growth. This innovative method enables the design of industrial strains of bacteria capable of efficient microbial electrosynthesis.

Applications


  • Biofuel and chemical commodities production.

Advantages


  • Efficient and robust storage of electrical energy.
  • Cost effective conversion of C1 compounds into sugars.

Technology's Essence


By engineering E. coli, the ”workhorse” bacteria used in biotechnology and enabling its growth on formate, researches at Dr. Ron Milo’s lab paved the way for efficient microbial electrosynthesis. The Researches started by investigating many metabolic pathways in order to discover how a model organism such as E.coli can be engineered for formatotrophic growth.  estimate which pathway is most suitable to support growth on formate each pathway was examined based on various criteria such as biomass yield, thermodynamic favorability, chemical motive force, kinetics and additional practical challenges. 
One short favorable pathway was consistently identified, that is the reductive glycine pathway. Furthermore.  Researches generated an isolated organism that is able to convert formate to pyruvate or glycerate.


Licensing Status


Pending

+
  • Prof. Ron Milo
1536
Designer cellulosomes are synthetic multi-enzyme complexes that can degrade cellulosic biomass efficiently and economically. The goal of second generation biofuel production is to efficiently convert agricultural waste, algae and other cellulosic biomass into sugar monomers.   Cellulosic biomass...

Designer cellulosomes are synthetic multi-enzyme complexes that can degrade cellulosic biomass efficiently and economically. The goal of second generation biofuel production is to efficiently convert agricultural waste, algae and other cellulosic biomass into sugar monomers.

 

Cellulosic biomass pretreated (e.g. with acid) under ideal conditions, still requires very high enzyme doses to provide efficient bioconversion.

The cost of enzymes and pretreatment is a major hurdle in the production of low-cost cellulosic biofuel, competitive with that of fossil fuels or ethanol produced from corn or sugarcane.

 

The complex structure of cellulosic materials is built to resist bacterial hydrolytic enzymes. The cooperation of many types of carbohydrate-active enzymes is required for effective degradation. By designing synthetic cellulosomes, researchers at The Weizmann Institute enhance synergy between carbohydrate-active enzymes to achieve remarkable degradation rates. Their discoveries can lead to highly efficient conversion of cellulosic biomass, and thus have a major impact in the field of food production and sustainable energy.

Applications


  • High-yield, cost-effective conversion of plant cell wall biomass into soluble sugars for the food industry and the production of biofuels and biochemicals.

Advantages


  • Bio-engineered cellulosomes exhibit synergistic degradation activity of natural substrates compared to the combined action of the free wild-type enzymes.

Technology's Essence


The invention involves the conversion of enzymes (cellulases and xylanases) from the free mode to the cellulosmal mode by attachment using a recombinant dockerin molecule. The dockerin-bearing enzymes are incorporated into designer cellulosomes by interacting with a matching cohesion-containing chimeric scaffoldin (scaffoldin subunits contain the cohesin modules that incorporate the enzymes into the cellulosome complex via their resident dockerins). This approach has generated over two fold enhancement of synergistic hydrolysis on plant cell wall cellulosic biomass. These results create new possibilities for designing superior enzyme compositions for degradation of complex polysaccharides into simple soluble sugars.

+
  • Prof. Edward A. Bayer
1582
Over-expression of an oil globule protein for increased production of oil. Oil globules are discrete organelles, ubiquitous in animals, microorganisms and plants. Plant oil globules contain specific proteins that are tightly bound to their surface. These proteins are suggested to have different roles,...

Over-expression of an oil globule protein for increased production of oil.

Oil globules are discrete organelles, ubiquitous in animals, microorganisms and plants. Plant oil globules contain specific proteins that are tightly bound to their surface. These proteins are suggested to have different roles, including globules formation, degradation and stabilization. The present invention relies on the fact that oil globule associated proteins stabilize the oil bodies, and suggests the induction of one of these proteins as a means to obtain high yields of oil globules. 

Applications


  • Higher yields of oil for food and biodiesel

  • Higher yield of the pigment astaxanthin or beta carotene in pigment-accumulating algae


Advantages


  • Obtaining valuable materials (oil and pigments) with a relatively simple manipulation (i.e., over-expression of the globule-associated protein)
  • Cost-effective

Technology's Essence


In many microorganisms (e.g., yeasts, micro-algae and bacteria), the accumulation of oil globules appears to be induced specifically in response to environmental stresses such as nutrient limitation, high irradiance or osmotic stress. One specific protein, found only in micro-algae, was enriched in isolated globules and in stressed cells, in correlation to astaxanthin accumulation. This correlation makes the protein a promising candidate to function in stress response, and more specifically, in globule buildup. Therefore, it may be expected that its over-expression in plants or in algae could increase the accumulation of oil (tryglycerides).

+
  • Prof. Uri Pick
1633
The ErbB family consists of four structurally related receptor tyrosine kinases. Excessive ErbB signaling is associated with enhanced tumorogenesis, and as such serves as a major therapeutic target in a wide array of solid tumor cancers. A member of this family, the human epidermal growth factor...

The ErbB family consists of four structurally related receptor tyrosine kinases. Excessive ErbB signaling is associated with enhanced tumorogenesis, and as such serves as a major therapeutic target in a wide array of solid tumor cancers. A member of this family, the human epidermal growth factor receptor 2 (ErbB-2/HER2), is overexpressed in a variety of human cancers, including breast and gastric tumors. ErbB-2/HER2 amplification correlates with elevated metastatic activity and poor prognosis. An innovative and highly potent approach for cancer treatment is proposed here, based on delivering novel nucleic acid-based entities called aptamers targeting ErbB-2/HER2. Remarkably, the antitumor effect exerted by the multimeric anti-ErbB-2/HER2 aptamers is twofold stronger than that elicited by currently available antiErbB-2 monocolonal antibodies.

Applications


  • A novel class of molecules for the treatment of human cancers exhibiting excessive ErbB-2/HER2 signaling.
  • Combination with other therapeutic modalities may predictably enhance the antitumor activity of the aptamer.
  • Aptamers may also be harnessed as carrier molecules to deliver toxic loads into cancer cells.

Advantages


  • Unlike traditional methods for producing monoclonal antibodies, no organisms are required for the in vitro selection of oligonucleotides. This facilitates the selection and chemical design process of aptamers.
  • Aptamers are produced chemically in a readily scalable process.
  • Non-immunogenic.
  • Unlike other oligonucleotide-based therapeutics (siRNAs, antisense RNA), aptamer therapeutics can be developed for intracellular as well as extracellular or cell-surface targets.

Technology's Essence


Aptamers are single-stranded oligonucleotides that fold into defined architectures and avidly bind to targets such as proteins, with the same effectiveness and affinity associated with mAbs. Using a novel screening technology the research team has identified a multimeric aptamer with pronounced ErbB-2/HER2 inhibitory activity. Preliminary preclinical experiments show that treatment of gastric tumor-bearing mice with trimeric aptamer resulted in reduced tumor growth that was nearly twofold stronger than that achieved with a monoclonal anti-ErbB-2/HER2 antibody.

+
  • Prof. Yosef Yarden
  • Prof. Michael Sela
1604
Novel reporter gene for magnetic resonance imaging applications.The ability to image the duration and location of gene expression in vivo and noninvasively is imperative for the future of biology and clinical medicine. Magnetic Resonance Imaging (MRI) is a widely used noninvasive clinical diagnostic...

Novel reporter gene for magnetic resonance imaging applications.The ability to image the duration and location of gene expression in vivo and noninvasively is imperative for the future of biology and clinical medicine. Magnetic Resonance Imaging (MRI) is a widely used noninvasive clinical diagnostic tool that offers views into deep tissues at exquisite spatial resolution. Recently, MRI has emerged as a valuable tool for monitoring the expression of genes by utilizing metal-complexed MRI agents to display transgene activity in vivo. However, administration of metal complexes into tissues and cells is challenging. Intra-cellular metalloproteins such as Ferritin have been utilized as endogenous MRI contrast agents, but offer relatively low sensitivity. The present technology provides a novel Ferritin-based transgene with enhanced MRI contrast.

 

Applications


  • Non-invasive imaging of gene expression in transgenic mice models.
  • Monitoring target gene expression in pre-clinical studies.
  • Long-term cell labeling and tracking.
  • Visualization of cellular- and gene-based therapeutics.

Advantages


  • Does not require delivery of exogenous substrate.
  • Enhanced MRI contrast over current Ferritin-based reporters.
  • Conversion to magnetite is achieved in physiological conditions and not by synthetic modification or by extreme heating. 

Technology's Essence


Ferritin, the main Iron storage intracellular protein, contains a paramagnetic ferryhydrate core, and thus was proposed as an endogenous MRI reporter gene. However, Ferritin provides relatively low sensitivity. One way to increase sensitivity of Ferritin is to convert the non-crystalline ferrihydrate in its core into crystal magnetite as has been done chemically, to form magneto-ferritin. The current method enhances the magnetic properties of Ferritin by engineering a Ferritin protein fused to a bacteria-derived peptide. This novel recombinant fusion protein facilitates conversion of ferrihydrate into crystal magnetite and by this induces MRI contrast. The new construct can serve for monitoring delivery and differentiation of cells in vivo in cellular based therapy. 

+
  • Prof. Michal Neeman
1664
Neuroinflammation is well established as a key secondary injury mechanism following CNS trauma, such as traumatic brain/spinal injury or ischemic stroke, and it has been long considered to contribute to the damage sustained and fatal outcomes following brain injury. Early inflammatory events enhance...

Neuroinflammation is well established as a key secondary injury mechanism following CNS trauma, such as traumatic brain/spinal injury or ischemic stroke, and it has been long considered to contribute to the damage sustained and fatal outcomes following brain injury.
Early inflammatory events enhance brain damage, yet they provide the framework for later inflammatory events that enhance tissue remodeling and are crucial for tissue recovery.
A major unmet need in the field is a targeted treatment that would down regulate the damaging events of inflammation, while maintaining reparative functions. 
Altering between CNS microglia pro and anti-inflammatory activation states is at the core of injury-induced neuroinflammation and presents an opportunity to specifically tilt the balance towards anti-inflammatory and repair processes.
The present discovery elucidates the mechanisms that lead to injury-induced microglia over-activation and proposes IFN-? as a therapeutic strategy to induce microglia resolving state and relive inflammation. 

Applications


Anti-inflammatory treatment following CNS injury

Advantages


  • Targeted therapy – avoids general immuno-suppressive side effects
  • Based on a well understood molecular mechanism
  • May allow relatively large therapeutic window – according to proof-of-concept  preliminary experiments

Technology's Essence


Resident microglia are the major specialized innate immune cells of the central nervous system (CNS). During the process of wound healing or pathogen removal, there is an induction of the microglia active pro-inflammatiry phenotype (M1), leading to a transient inflammatory response, which is resolved via local conversion to the M2 anti-inflammatory phenotype.  Following acute injury, microglia fail to acquire an inflammation-resolving phenotype (M2-like phenotype) in a timely manner, often resulting in self-perpetuating local inflammation and tissue destruction beyond the primary insult.
Prof. Schwartz and her team uncovered the mechanisms that lead to injury-based inhibition of the M1 to M2 phenotype switch.  They showed that the capacity to undergo pro- to anti-inflammatory (M1-to-M2) phenotype switch is controlled by the transcription factor Interferon regulatory factor-7 (IRF7).  Their results demonstrate that restoring Irf7 expression by IFN-? (a known IRF7 activator) reactivates the circuits leading to M2 conversion by improving the resolution of pro?inflammatory cytokines expressed by microglia ex vivo and in vivo, following acute CNS insult.
Importantly, the anti-inflammatory activity of IFN-? was demonstrated in-vivo, when administrated 24h following the primary insult, proposing a relatively large therapeutic window.

+
  • Prof. Michal Eisenbach-Schwartz
1551
A novel set of manganese, ruthenium and related borohydride complexes (Pincer-type) were developed as remarkably efficient and environmentally-benign catalysts for the synthesis of alcohols, amines, amides, imines and esters, which are the basic building blocks for the research, chemicals,...

A novel set of manganese, ruthenium and related borohydride complexes (Pincer-type) were developed as remarkably efficient and environmentally-benign catalysts for the synthesis of alcohols, amines, amides, imines and esters, which are the basic building blocks for the research, chemicals, pharmaceutical and agrochemical industries. In addition, a catalytic carbon-carbon bond formation using non-activated aliphatic nitriles and carbonyl compounds was achieved with the manganese complex. These reactions are conducted under mild and neutral conditions, using low catalyst loading, require no hydrogen acceptors or oxidants, employ no corrosive or toxic reagents and generate no waste. Moreover, manganese is one of the most abundant transition metals on earth crust, making it appealing and biocompatible when considering a system for eventual scale-up and industrial use.

In view of global concerns regarding economy, environment and sustainable energy resources, there is an urgent need for the discovery of new catalytic reactions. These newly developed catalysts address key problems of current traditional synthetic methodologies, both from the economic and the environmental aspects.

Applications


·         Pharmaceuticals

·         Dyes

·         Cosmetics and fragrances

·         Fibers

·         Agrochemicals


Advantages


·         Cost-effective in terms of reagents, reactions conditions (low temperature and pressure) and waste treatment (green reactions).

·         New synthetic pathways that were not possible before, such as the synthesis of amides and imines directly from alcohols and amines, esters synthesis from alcohols and methanol synthesis from CO2 and hydrogen.

·         Broad substrate scope.

·         Excellent yields.


Technology's Essence


Prof. David Milstein’s group has discovered a new mode of action for metal-ligand cooperation, involving aromatization–dearomatization of ligands. Pincer-type, pyridine-based complexes of Mn, Ir, Rh, Ru, Pd, Pt and acridine complexes of Ru have been shown to exhibit such cooperation, leading to facile activation of C-H, C-C, H-H, N-H, O-H bonds, and to novel, environmentally friendly reactions catalyzed by Mn and Ru.

+
  • Prof. David Milstein
1585
Our scientific team has discovered a method to apply the Gabor Transform to signal processing and data compression. Compared to existing methods that are based on Fourier transform, the new method provides for up to 25% savings in content size for video, audio and images, without any loss in quality...

Our scientific team has discovered a method to apply the Gabor Transform to signal processing and data compression.

Compared to existing methods that are based on Fourier transform, the new method provides for up to 25% savings in content size for video, audio and images, without any loss in quality.

By embracing our method, content providers, ISPs and mobile carriers can achieve major savings in data storage and data transfer costs.

Applications


The method can be used in virtually all applications involving data storage, communication and signal processing. One of the main commercial application is for lossy data compression for video, audio and images. Those types of content constitute the bulk of today’s Internet traffic, and improved compression will generate substantial savings in storage and data transfer costs.

The method also applies to the storage, communication and processing of quantum information and may therefore be expected to have applications in quantum calculations, quantum communication and quantum information processing.


Advantages


Existing data compression methods are based on numerical implementations of the Fourier transform, known as FFT, DCT and similar.

Compared to these methods, Gabor transform method demonstrates a very significant advantage in terms of the size of compressed material.  

The method provides for up to 25% savings in data size, while keeping the same perceived quality of the content.


Technology's Essence


We have discovered the definitive solution to the problem of obtaining accuracy and stability in the Gabor transform.  We realized that there must be an exact informational equivalence between the Gabor transform and the discrete Fourier transform (DFT). The latter is known to provide an exact representation of functions that are band-limited with finite support.  Since the DFT implicitly assumes periodic boundary conditions, to obtain this exact equivalence one needs to modify the Gaussians in the Gabor transform to obey periodic boundary conditions. This leads to Gaussian flexibility with Fourier accuracy --- precisely what has been sought since 1946.

+
  • Prof. David J. Tannor
1643
Improving beta cell isolation and purification techniques is a critical step towards the development of new cell-based therapies, diagnostic applications and diabetes research. Pancreatic Islets are composed of mixed cell populations, among them beta cells, which represent a major focus of interest due...

Improving beta cell isolation and purification techniques is a critical step towards the development of new cell-based therapies, diagnostic applications and diabetes research. Pancreatic Islets are composed of mixed cell populations, among them beta cells, which represent a major focus of interest due to their participation in the pathology of diabetes. Various techniques have been suggested to accomplish this step, yet efficient and robust isolation of beta cells remains a challenging task.
The present invention provides an efficient tag-free isolation method for pancreatic cell sub-types, based on separation according to a newly identified collection of surface markers. These markers are tightly correlated with specific functions, such as insulin production, ensuring enrichment of the desired functionality.
Probing against the newly identified markers in a combinatorial manner allows high degree of purity without compromising the yield, significantly increasing the amount of purified cells. Finally, the method is compatible with both extracts of pancreatic tissues and stem cells derived cultures, the latter set up high expectations in the diabetes therapy field.

Applications


A kit for isolation of distinct pancreatic cell subtypes

Advantages


  • High purity without compromising the yield of isolated cells.
  • Compatible with a variety of heterogeneous sources including cells extracted from pancreatic tissue, committed lineages of stem cells and cultures of differentiated stem cells.                                               

Technology's Essence


Using an innovative high throughput screen, linking specific cell surface markers with a particular functionality (e.g. insulin production), a collection of markers not previously identified in connection with pancreatic cells or with diabetes was found to be consistently expressed in human islets.
Cell isolation according to the selected markers is performed by exposing the heterogeneous source of cells to specific antibodies that recognize these markers, followed by a choice of sorting techniques such as fluorescence activated cell sorting (FACS).
The innovative concept of this method is the use of marker combinations, iterating the selection. Only cells that express both markers will be sorted out, thus increasing specificity and reducing contaminations. This increased specificity gives rise to a higher degree of purity without compromising the yield, resulting in larger amounts of isolated cells.
By applying the initial screen in yet another iteration, additional markers can be added to the selection, to refine the isolation procedure. 
As this method is generally applicable to the purification of mature as well as pluripotent or partially differentiated beta cell progenitors, it holds great potential for the isolation of clinically relevant cells for treatments of diabetes.

+
  • Prof. Michael Walker
  • Prof. Michael Walker
1615
A new process for the production of catalytic metal coated WS2 nanotubes, using cobalt, palladium, nickel, chromium and noble metals.These metal coated nanotubes were shown to have catalytic activity in different organic reactions including degradation of known organic contaminants (Co coated) and...

A new process for the production of catalytic metal coated WS2 nanotubes, using cobalt, palladium, nickel, chromium and noble metals.
These metal coated nanotubes were shown to have catalytic activity in different organic reactions including degradation of known organic contaminants (Co coated) and Suzuki and Heck coupling reactions (Pd coated).
Since catalytic chemical reactions are at the heart of many processes and industries, and efficient catalysis is essential for both economic and environmental reasons, this development of a new catalytic platform bears a potential to influence many diverse markets.

Applications


  • New and efficient Pd-based catalysts for diverse reactions.
  • New and efficient crude oil HDS catalysts.
  • New and efficient wastewater purification catalysts.
  • Production of activated hybrid WS2 nanotubes with new properties.
  • Tailoring catalytic nanotubes with different band gaps adjusted to different activation and catalysis applications.

Advantages


  • Formation of highly active catalytic nanotubes
  • Utilization of the nanotubes' very large surface area
  • Recruiting specific nanotube semiconducting characteristics for special catalysis requirements

Technology's Essence


The invention involves deposition of metal nanoparticles on prepared WS2 nanotubes (INT-WS2) in a two stage process involving Pd-nanocrystallites assisted activation followed by electroless plating.
In this process WS2 nanotubes are synthesized according to known procedures. The nanotubes are then covered by metal nanoparticles in a simple and straightforward procedure resulting with highly active nanotubes which can be utilized as catalysts for various chemical reactions.
This new hybrid technology opens the way to a new family of highly efficient, tunable catalysts; the INTs large surface area, specific band gap design and choice of metal result in an ability to produce unique tailor-made catalysts, applicable to many different industries. 

+
  • Prof. Tenne Reshef
  • Prof. Tenne Reshef
1555
Albumin binding probe for extending the lifetime of drugs. Most polypeptide drugs, in particular non-glycosylated proteins of molecular mass less than 50 kDa, are short-lived species in vivo having circulatory half lives of 5-20 min. Drug association with endogenous albumin may be suitable for...

Albumin binding probe for extending the lifetime of drugs. Most polypeptide drugs, in particular non-glycosylated proteins of molecular mass less than 50 kDa, are short-lived species in vivo having circulatory half lives of 5-20 min. Drug association with endogenous albumin may be suitable for designing an approach to protract the action in vivo of, potentially, any short-lived peptide/protein drug. In doing so two principal obstacles must be overcome: (1) following its conjugation, the probe introduced into a peptide or a protein should have sufficient affinity to albumin to manifest prolonged action in vivo, and (2) in case such covalent introduction results in an inactive product, the latter should be capable to undergo slow reactivation at physiological conditions. The present invention relates to engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions.

Applications


  • Prolonging half life of short-lined drugs

Advantages


  • Prolonging the action of the drug without effecting its activity 
  • A desirable pharmacokinetic pattern

Technology's Essence


Since albumin is long-lived in vivo, drugs and endogenous substances that tightly associate with it have lower clearance rates than that of the unbound substances, and exhibit prolonged lifetime profiles in vivo. The present invention is based on a concept according to which a long chain fatty acid (LCFA) like albuminbinding compound is covalently linked to a short-lived amino-containing drug to form a non-covalent drug conjugate capable of associating with albumin in vivo, i.e., a long-lived prodrug that gradually releases the pharmacologically active constituent. This approach has been successfully implemented with several drugs (e.g. insulin, exendin and gentamicin).

+
  • Prof. Matityahu Fridkin
  • Prof. Yoram Shechter
1593
The study of social behavior in groups of mice may have crucial implications for understanding the social aspects of different disorders.  To be executed correctly, group studies require the ability to track individual’s behavior within the group structure. The main challenge of current research tools...

The study of social behavior in groups of mice may have crucial implications for understanding the social aspects of different disorders. 
To be executed correctly, group studies require the ability to track individual’s behavior within the group structure. The main challenge of current research tools is to allow individuals identification while maintaining sufficient resolution for accurate tracking.
The present technology provides a system that utilizes fluorescent fur dyes to differentially mark and track individuals within a group. Using a sensitive color camera and a newly designed tracking algorithm, behavior of groups may be recorded and analyzed with high temporal and spatial resolution.   
The technology further offers a method for characterizing the group’s interactions using the maximum entropy model.

 

Applications


 


Advantages


  • High spatial and temporal resolution – enabled by sensitive color video tracking.
  • Enables high detailed analysis of individual behavior within the group.
  • Suitable for community study of groups - limited only by available fur dyes.
  • Compatible with long-term analysis.
  • Simple, cost effective.
  • Minimal suffering and improved animal welfare.

  • Technology's Essence


    The present technology takes advantage of the fact that mice are nocturnal (active at night) animals, to mark their fur with different fluorescent dyes. Under ultraviolet light, the mice can be accurately and automatically tracked, over a number of days. As the mice are allowed to move freely in an interesting arena for exploration containing ramps, nest boxes and barriers (Figure 1), their trajectory and behavior are recorded using a sensitive color camera.
    The system further includes an image processing module which analyses the recorded images, calculates a spatiotemporal model and the nature of social interactions between individuals.
    Combining detailed behavioral and genetic analysis ate the level of individuals, in association with group analysis, may enable the identification of genetic and neuronal correlates of complex social interactions. 

    +
    • Prof. Alon Chen
    1646
    Dedicated and highly efficient EPR analysis of small volume samples in a range of few µl is now made simple with a novel device invented at the Weizmann Institute of Science. This device features a new ejection mechanism and a unique cold trap which enables collection of all time points in a RFQ series...

    Dedicated and highly efficient EPR analysis of small volume samples in a range of few µl is now made simple with a novel device invented at the Weizmann Institute of Science. This device features a new ejection mechanism and a unique cold trap which enables collection of all time points in a RFQ series in one continuous experiment.
    In order to design and develop inhibitors for therapeutic purposes, the reaction mechanisms of enzymes must be understood. For biological applications, a common methodology of addressing this need is combining Rapid Freeze Quench with Electron Paramagnetic Resonance (RFQ)-EPR, which allows the trapping and analysis of short lived intermediates in chemical reactions. However, commercial RFQ-EPR devices are limited for high field EPR applications due to the demand of large sample volumes for each time point.
    Prof. Goldfarb and her team built a new RFQ apparatus based on microfluidic flow and unique ejection and freezing systems, which can be used for collecting small volume samples in capillaries for high field EPR.

    Applications


    This technology, combined with the variety of W-band high resolution EPR technique (ENDOR, DEER and ESEEM) enables better mechanistic studies of enzymatic reactions, with an emphasis on structural transformations during the reaction, in an efficient and accurate way.


    Advantages


    • Collecting all RFQ time points in one continues experiment.
    • Produce small volume samples in the range of a few µl, and handles small capillaries, for high field ERP.
    • An improved dead time of ~5ms, relative to the commercial RFQs with a typical dead-time of 5–10 ms.
    • Ease-of-use and speed.

    Technology's Essence


    The innovative apparatus consists of two main parts: the microfluidic device and the freeze-quench setup. The microfluidic device comprises a mixer, which mixes the two reacting solutions, a flow path where the reaction occurs, and a sprinkler from which the solution is sprayed out of the device. Prof. Goldfarb and her colleagues improved the common mixing device by adding a fast stream of nitrogen gas which mixes with the ejected reaction solution, and sprays the frozen aerosol out in tiny drops at high speed.
    The innovative RFQ device was planned to have a cold solid surface on which the freezing happens rather than the traditional ejection into a cold liquid, in order to minimize the losses of the frozen solution. Moreover the plate rotates at a speed correlated to the flow speed of the solution, thus samples of different reaction times can freeze on a different radius. The frozen samples are then collected into quartz capillaries.

    +
    • Prof. Daniella Goldfarb
    1564
    A new recyclable size-selective filtration device. Particle size, chemical purity and dispersion of nanoparticles crucially determine their optical, electronic and chemical properties. Size-selective separation technologies are becoming increasingly important for the development of nanoparticles with...

    A new recyclable size-selective filtration device.

    Particle size, chemical purity and dispersion of nanoparticles crucially determine their optical, electronic and chemical properties. Size-selective separation technologies are becoming increasingly important for the development of nanoparticles with well-defined sizes, which have application in the fields of optoelectronic devices, biomedicine, materials, and catalysis.

    Researchers at the Weizmann Institute have fabricated supramolecular ultrafiltration membranes that can be used for filtration and size-selective chromatography of nanoparticles. The membranes are composed of a self-assembled three-dimensional fibrous network that is held together by reversible non-covalent interactions.

    The membranes are robust, easy to fabricate, and recyclable.

    Applications


    • Size-selective separation of semiconductor and metal nanoparticles
    • Uniformity and monodispersity of nanoparticles in solution.
    • Size exclusion chromatography of nanoparticles in the sub-5-nm size regime.

    Advantages


    • Efficient and inexpensive

    • Fast and easy fabrication

    • Recyclable

    • Self-assembled

    • Dual application regime: filtration and/or chromatography


    Technology's Essence


    The recyclable supramolecular membranes are formed from unique perylene derivatives that are large and flat aromatic molecules. These molecules are insoluble in water and form a 3-D network over a solid support, which can be used for the separation of nanoparticles.

    The filters can be subsequently recycled from this mixture using an organic solvent (e.g. dichloromethane), which separates the membrane material from the water-soluble nanoparticles, and reused without loss of performance.

    This material is hence highly attractive for application in the field of nanotechnology.

    +
    • Prof. Boris Rybtchinski

    Pages